BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8123971)

  • 21. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group.
    Lancet; 1990 Jul; 336(8707):71-5. PubMed ID: 1975322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators.
    Califf RM; Woodlief LH; Harrell FE; Lee KL; White HD; Guerci A; Barbash GI; Simes RJ; Weaver WD; Simoons ML; Topol EJ
    Am Heart J; 1997 Jun; 133(6):630-9. PubMed ID: 9200390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does intravenous heparin or time-to-treatment/reperfusion explain differences between GUSTO and ISIS-3 results?
    Anderson JL; Karagounis LA
    Am J Cardiol; 1994 Nov; 74(10):1057-60. PubMed ID: 7977047
    [No Abstract]   [Full Text] [Related]  

  • 24. More on the GUSTO Trial.
    Lomaestro BM
    Ann Intern Med; 1994 Nov; 121(10):818-9. PubMed ID: 7944069
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolytic therapy of myocardial infarction--it's time for science, not marketing: the perspective of a practicing cardiologist.
    Vogel JH
    Clin Cardiol; 1991 Jul; 14(7):548. PubMed ID: 1810292
    [No Abstract]   [Full Text] [Related]  

  • 26. Long term effects of thrombolytic therapy in acute myocardial infarction.
    Shah LS
    J Assoc Physicians India; 1994 Jan; 42(1):9-11. PubMed ID: 7836276
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolytic therapy for myocardial infarction.
    Guerci AD
    Md Med J; 1990 Apr; 39(4):377-81. PubMed ID: 2110282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future directions in thrombolysis for myocardial infarction: what are the unanswered questions?
    Lefkovits J; Topol EJ
    Coron Artery Dis; 1994 Apr; 5(4):306-16. PubMed ID: 8044342
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze.
    Zahn R; Rustige J; Koch A; Schiele R; Burczyk U; Schuster S; Harmjanz D; Boppert D; Gottwik M; Neuhaus KL; Senges J
    Am J Cardiol; 1997 Nov; 80(10):1339-43. PubMed ID: 9388110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perspectives on therapeutic interventions in patients with acute myocardial infarction: viewpoints after the GISSI-2 results.
    Maggioni AP; Franzosi MG; Malacrida R; Tognoni G
    Clin Cardiol; 1991 Jul; 14(7):549-56. PubMed ID: 1747963
    [No Abstract]   [Full Text] [Related]  

  • 31. Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
    Krucoff MW; Green CL; Langer A; Klootwijk LJ; Trollinger KM; Sawchak ST; Wilderman NM; Veldkamp RF; Pope JE; Simoons ML
    J Electrocardiol; 1993; 26 Suppl():249-55. PubMed ID: 8189133
    [No Abstract]   [Full Text] [Related]  

  • 32. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 33. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
    Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

  • 35. [Coronary thrombolysis].
    Kamimatsuse K
    Kokyu To Junkan; 1993 Nov; 41(11):1033-42. PubMed ID: 8256043
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of thrombolytic therapy in normally menstruating women with acute myocardial infarction.
    Lanter PL; Jennings CF; Roberts CS; Jesse RL
    Am J Cardiol; 1994 Jul; 74(2):179-81. PubMed ID: 8023787
    [No Abstract]   [Full Text] [Related]  

  • 37. Tissue-type plasminogen activator for acute coronary thrombosis.
    Med Lett Drugs Ther; 1987 Dec; 29(754):107-9. PubMed ID: 3119965
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute myocardial infarction: a true medical emergency.
    White HD
    N Z Med J; 1989 Jun; 102(869):281-3. PubMed ID: 2499853
    [No Abstract]   [Full Text] [Related]  

  • 39. Mortality results in GUSTO.
    Van de Werf F
    Aust N Z J Med; 1993 Dec; 23(6):732-4; discussion 735-6. PubMed ID: 8141713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More on the GUSTO Trial.
    Ridker PM; O'Donnell C; Marder VJ; Hennekens CH
    Ann Intern Med; 1994 Nov; 121(10):818. PubMed ID: 7944067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.